Investment Thesis
Merck is operating at a critical profitability crisis with -$4.2B net income, -26.0% net margin, and inability to cover interest from operations (-11.7x coverage). While positive free cash flow ($2.9B) provides near-term survival cushion, the combination of severe losses, high leverage (1.02x debt-to-equity), and negative returns on equity/assets signals fundamental operational distress requiring urgent resolution.
Strengths
- Positive free cash flow of $2.9B despite massive accounting losses suggests underlying business stability
- Large asset base of $128.7B indicates substantial portfolio of productive assets and valuable IP
- Improving EPS trajectory (+8.0% YoY) and modest revenue growth (+1.3% YoY) suggest potential stabilization
Risks
- Operating income of -$3.5B and net margin of -26.0% indicate severe operational distress beyond temporary charges
- Unable to cover interest expenses from operations with -11.7x interest coverage and high debt load of $46.7B relative to $5.3B cash
- Debt-to-equity ratio of 1.02x combined with negative profitability creates unsustainable capital structure and refinancing risk
Key Metrics to Watch
- Return to operating profitability and positive net margin trajectory
- Interest coverage ratio improvement and debt reduction relative to equity
- Sustainability of operating cash flow generation and underlying business cash conversion
Financial Metrics
Revenue
16.3B
Net Income
-4.2B
EPS (Diluted)
$-1.72
Free Cash Flow
2.9B
Total Assets
128.7B
Cash
5.3B
Profitability Ratios
Gross Margin
N/A
Operating Margin
-21.7%
Net Margin
-26.0%
ROE
-9.2%
ROA
-3.3%
FCF Margin
18.0%
Balance Sheet & Liquidity
Current Ratio
1.30x
Quick Ratio
1.06x
Debt/Equity
1.02x
Debt/Assets
0.0%
Interest Coverage
-11.66x
Long-term Debt
46.7B
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-06T18:19:56.668085 |
Data as of: 2026-03-31 |
Powered by Claude AI